Boston Scientific (BSX) Interest Expenses (2009 - 2026)

Boston Scientific has disclosed Interest Expenses across 18 years of filings, most recently posting $90.0 million for Q1 2026.

• Interest Expenses for Q1 2026 came in at $90.0 million, up 9.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $357.0 million (up 12.26% YoY), and the FY2025 annual result was $349.0 million, up 14.43% from the prior year.
• Interest Expenses came in at $90.0 million for Q1 2026 at Boston Scientific, roughly flat from $90.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $279.0 million in Q1 2022 to a low of $63.0 million in Q3 2022.
• The 5-year median for Interest Expenses is $77.0 million (2024), against an average of $87.1 million.
• Across the five-year window, Interest Expenses surged 240.24% in 2022 and tumbled 76.7% in 2023, its largest moves.
• Boston Scientific's Interest Expenses stood at $64.0 million in 2022, then gained by 1.56% to $65.0 million in 2023, then rose by 23.08% to $80.0 million in 2024, then climbed by 12.5% to $90.0 million in 2025, then changed by 0.0% to $90.0 million in 2026.
• The last three Interest Expenses figures came in at $90.0 million (Q1 2026), $90.0 million (Q4 2025), and $87.0 million (Q3 2025), per Business Quant data.